Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific GAAP R&D % of Total Revenue by Quarter
GAAP R&D % of Total Revenue (%)
Thermo Fisher Scientific GAAP R&D % of Total Revenue: 2.9% in Q3 2026, down 0.2 pts from a year earlier. That is the lowest of the 15 quarters on record here.
Where the Q3 2026 figure comes from
“GAAP R&D expense 342 3.3 % 352 3.2 % 346 3.1 % 357 2.9 % 336 3.1 % 364 3.0 % 348 2.9 %”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific GAAP R&D % of Total Revenue (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/gaap-rd-reconcil-pct
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.